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In  studying  the  relation of  the  envelope antigens  of  oncorna viruses  (1)  to  the 
antigens of cells they infect, it is necessary to consider: (a) infection, the penetration 
of virus into the cell, which may possibly leave residual antigens at the cell surface 
(2); (b) virus-directed synthesis of cell-surface components unrelated to the construc- 
tion of virions (3,  4);  and  (c)  virus assembly at  the  cell surface,  during which  the 
nucleocapsid becomes progressively enveloped by an outer membrane which is con- 
tinuous with  the plasma membrane  of  the  cell (until maturation  is complete) and 
which  may or  may not  differ  from  it  morphologically,  according  to  the  type  of 
virus concerned (5-7). 
In addition to problems relating to the constitution of the viral envelope, and to 
modifications of  cell-surface composition  resulting  from  infection,  there arises the 
important question of whether the maturation of virus can take place at any region of 
the cell surface, or whether this is in any way governed by the remarkable regional 
differentiation which  has  recently been recognized as characteristic of cell surfaces. 
We have  already reported  that  H-2  alloantigen and  GCSA  I  (a  cell-surface 
nmrine  leukemia virus  (MuLV)-associated  antigen)  were  not  present  on  the 
envelope of MuLV  from  leukemia cells (E~G2)  induced by passage A  Gross 
virus, and that budding appeared  to take place preferentially at H-2-GCSA- 
regions of the cell surface (4). In this communication we report an extension of 
these findings to  other known  antigens, cell-specified which contribute  to  the 
composition of the cell surface. 
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Materials and Methods 
Serological Test Systems.  See Tables I  and II. Medium 199 was used as the diluent and 
suspending medium. 
Absorption of Antiserum.- 
In vitro:  The test serum was diluted to two doubling dilutions below the end point of the 
cytotoxic test, mixed with an equal volume of packed washed cells, incubated for 30 rain at 
4°C, and recovered by centrifugation in the cold. 
In vivo:  To remove anti-mouse heteroantibody, the rat MuLV t3~ping serum (W/Fu X 
BN)F1 anti-W/Fu(CSgNT)D  (10) was absorbed in vivo in 2-month-old C57BL/6 (B6) mice; 
1 ml of undiluted antiserum was injected intraperitoneally and recovered 21/2 hr later by cardiac 
puncture. The absorbed antiserum did not react with EL4 cells (GCSA-) in immunoe]ectron 
microscopy (IEM) tests, confirming that absorption of heteroantibody was complete. 
TABLE  I 
Test Systems for H-2, 0 (8), Ly-A, and Ly-B  (9) Alloantigens on Leukemia Cells 
Leukemia (test cell) 
B6 transplanted leukemia E o" G2, 
induced  by  passage  A  Gross 
virus;  (genotype of B6 mice is 
H-2 b: 0-C3H : Ly-A.2 : Ly-B .2) 
Transplanted  AKR spontaneous 
leukemia  K36  ascites  cells; 
(genotype of AKR mice is  H- 
2 k : 0-AK R:Ly-A.2 :Ly-B.1) 
* Congenic strains. 
Antiserum  Specificity 
B6/H-2 k* anti-B6 leukemia EL4  H-2b(2,  6,  14,  22, 
27, 28, 29, 33) 
A/0-AKR* anti-A strain spon-  0-C3H 
taneous leukemia ASL1 
C3H/An anti-CE thymocytes  Ly-A.2 
(C3H/An  X  B6/Ly-B.I*)F1  Ly-B.2 
anti-B6  radiation  leukemia 
ERI,D 
AKR/H-2b*anti-AKRleukemia  H-2k(1,  3,  8,  11, 
K36  25, 32) 
C3H/An anti-AKR thymocytes  0-AKR 
C3H/An anti-CE thymocytes  Ly-A.2 
B6/H-2 k anti-CE thymocytes  Ly-B.1 
Antigen Labeling.--5-10 X  106 washed viable test cells were incubated in the relevant anti- 
serum  (considerable excess antibody was always used). After two washings, the cells were 
incubated with anti-mouse-TG/anti-southern bean mosaic virus (SBMV)  F(abt)2  or  anti-rat- 
~/G/anti-ferritin F(ab%  hybrid  antibody.  The  concentration of  hybrid  antibody  was  ap- 
proximately 0.05 mg/ml with respect to anti-TG. (For detailed information on the hybrid anti- 
body preparation see references 11, 12.) Mter two more washings, the cells were incubated with 
SBMV (0.05 ml of 10 mg/ml) or ferrifin (0.05 ml of 0.05 mg/ml, six times crystallized) and 
then were finally washed twice. The incubations were carried out for 30 min at 0°C with oc- 
casional shaking, and washings were done in the cold. 
Electron Microscopy.~he final pellets of viable cells were covered with 2 ml of buffered 
2% glutaraldehyde for 20 rain at 0°C. After fixation for 60-90 rain in cold buffered 1% osmium 
tetroxide, they were kept overnight in cold 0.5% uranyl acetate, then dehydrated with ethanol 
and  embedded in Epon. Thin sections were cut on a  Sorvall MT-2  ultramicrotome (Ivan 
Sorvall  Inc., Norwalk, Conn.) with a diamond knife, stained with 5% uranyl acetate in alco- 
holic solution and lead citrate, and examined with a Siemens Etmiskop 1A electron microscope 
(Siemens Corp., Electromedical Div., Iselin, N.J.). : TADAO AOKI  AND  TOSHITADA TAKAHASHI  445 
More than  100 virions and  100 cells of each sample were observed to determine whether 
antigens are present on or absent from the viral envelopes and cell surfaces.  In order to avoid 
observing the same cells in different sections of one embedded sample, thin sections were ob- 
tained from eight blocks of each specimen. 
TABLE II 
Test Systems for GMuLV Antigens and PC Alloantigen on Mydoma Cells, Leukemia Cells, and 
Spleen Cells 
Tested on 
i  Antiserum  Absorbed with  i 
!  MOPC-70A  BALB  i  E&G2  B6  BALB 
i  mveloma  cells  leukem a cells  spleen  cells 
.....  __i  ........... 
I  Known antigens identified 
(B6 X  DBA/2)F1 anti- 
MOPC-70A (standard 
anti-PC.1  typing  se- 
rum)  (15) 
Serum  from  untreated, 
aged  autommune 
NZB mice 
(W/Fu  >(  Bn)F1  anti- 
W~ Fu (C58NT) D 
(standard  MuLV 
[Gross]  typing  serum 
prepared in rats)  (10) 
BALB spleen 
Ec~G2 
BALB spleen 
+  Ec~G2 
MOPC-70A 
In vivo in 
young B6 
mice 
GCSA (23),* 
PC (15) 
GCSA 
PC 
See Results 
See Results 
GCSA (23) 
GCSA 
GVEA~ (4) 
j  GCSA (23), 
GVEA (4) 
J 
PC (15) 
PC 
NT§ 
* GCSA, G  (Gross)  cell-surface antigen, previously designated  G antigen  (17). 
:~ GVEA, G  (Gross)  viral envelope antigen (4). 
§ NT, not tested. 
RESULTS 
H-2,  O, Ly-A, and Ly-B Antigens on the Two GCSA + Leukemias, Ec~G2 (B6) 
and K36 (AKR).--These observations are summarized in Fig. 1. 
Ec~G2 (strain of origin: B6-genotype H-2  b,  O-C3H, Ly-A.2, Ly-B.2):  H-2 b, 
0-C3H,  and Ly-A.2  antigens  were detected  on  small discrete  areas  of the  cell 
surface in some but not all sections (Figs. 2 and 3). Ly-B.2 was not demonstra- 
ble.  A  small proportion  (approximately  1/~)  of both  budding  and extracellular 
MuLV  produced  by  Ec~G2  cells were  labeled by  anti-0-C3H  antiserum.  The 
label invariably appeared  on only a  small sector of the envelope; in no case was 
the  entire  circumference  labeled.  H-2  b, Ly-A.2,  and Ly-B.2  antigens  were  not 
detected on virions at any stage of maturation  (Fig. 1). 446  ANTIGENS  OF  MURINE  LEUKEMIAS  AND  MYELOMAS 
K36 (strain, of origin,: AKR-genotype  H-2  k,  O-AKR, Ly-A.2,  Ly-B.1):  H-2  k 
and Ly-B.1 antigens were detected on small discrete areas of the cell surface in 
some but not all sections.  0-AKR and Ly-A.2 were not detectable. About one- 
fourth of the virions associated with K36, both incomplete (budding) as well as 
complete (extracellular),  showed a  restricted  H-2  k sector on the viral envelope 
(Figs.  4  and  5). As the  serum giving this  reaction, H-2  u vs. H-2  k prepared  in 
H-2 congenic mice, gave no reaction with ECG2  cells  (H-2 b)  or its associated 
virions, this labeling of a sector on viral envelopes from K36 can confidently be 
ascribed  to H-2 k.  0-AKR, Ly-A.2, and Ly-B.1 antigens  were  not detected  on 
the viral envelope. 
H-2 
E 
AIIoontigen Locus 
cx-A  cx-o 
~ppm~ I/8 VirlOnS 
~ppro~ 114 q,ocns 
FIG. 1.  Summary analysis of H-2, 0, Ly-A, and Ly-B antigens on the cell surface and the 
viral envelope of two Gross leukemias, ECG2 and K36. 
Once again,  as in the case of  0-labeling of ECG2  (above),  the labeling pro- 
duced by H-2 antiserum  on K36 virions was restricted  to small sectors of the 
viral envelope, and in no case was the entire circumference labeled (Figs. 4 and 
5). 
PC, GCSA,  and GVEA  on (a) MOPC-70A  Myeloma Cells,  (b) EcPG2 Gross 
Leukemia Cells', and  (c)  Xormal BALB/c  (BALB)  Spleen  Cells.--We  shall  be 
concerned here with known antigens of three classes: (a) the differentiation allo- 
antigen (13, 14), PC (15), which is found on myeloma cells but not on leukemia 
cells,  (b)  the  nonvirion MuLV-associated,  cell-surface antigen,  GCSA, and  (c) 
the  Gross viral envelope antigen,  GVEA, which is found on Gross (wild-type) 
murine leukemia virus (GMuLV). 
In order  to study the possible  representation  of PC cell-surface antigen  on 
virions produced by PC  + cells (myeloma cells and their nonmalignant counter- 
parts),  we employed the  standard  PC.1  typing serum  (B6 X  DBA/2)F1 anti- TADAO  AOKI  AND  TOSHITADA  TAKAHASHI  447 
FIG. 2.  Ec?G2 cells were reacted with  the serum O-ARK anti-O-C3H and  labeled with 
SBMV. Small areas on the cell surface are labeled with SBMV but the viral envelope is not 
labeled at all. X  144,000. 
Fro. 3.  Ec~G2 cells were reacted with the serum C3H/An anti-EC thymocytes (anti-Ly- 
A 2) and labeled with SMBV but the viral envelope is not labeled at all. X  72,000. 
BALB myeloma MOPC-70A  (15).  According to the  cytotoxic test,  the method 
by which  the  PC  antigenic  system  was  described,  this  antiserum  detects  only 
PC  antigen,  but  IEM  reveals  the  presence  of  additional,  MuLV-associated 
antibodies  that  are  not  apparent  by  cytotoxicity.  A  summary  analysis  of  the 
data is given in Fig. 6, which is largely self-explanatory. 
PC antigen was seen to be represented on discrete areas of the surface of PC  + 448  ANTIGENS OF  MURINE LEUKNMIAS AND  MYELOMAS 
spleen cells (Figs. 7 and 8), like all other cell-surface alloantigens so far studied 
(see above and reference  16). The  reaction with EoZG2  leukemia cell surfaces 
shows that anti-GCSA is present in the PC typing serum (although not demon- 
Fits. 4 and 5.  K36 cells were reacted with the serum  H-2  b anti-H-2 k  and  labeled with 
SBMV. Small areas on both the cell surface and the envelope of budding viruses are labeled 
with SBMV. Fig. 4,  ;< 72,000; Fig. 5,  ;<  144,000. 
strable by cytotoxicity) (Fig. 9). Furthermore, the antiserum contains antibody 
to  a  third  antigen,  tentatively  named  xVEA,  which  identifies a  new  virion 
antigen  present  on  the  myeloma  virions  but  lacking from  the  leukemia  cell 
virions both originally derived from passage A  Gross virus (Figs. 9 and 10) and TADAO AOKI  AND  TOSHITADA  TAKAHASHI  449 
SERUM:  ABSORBED:  REACTED WITH:  INTERPRETATION 
MOPC-70A  BALB  EcYG2  Gross  Cells from immunized 
myeloma cells  leukemia cells  BALB spleen 
(pc  +)  (PC-)  (PC +  ) 
(GCSA  +)  (GCSA  +)  (GCSA-) 
:T~  ~  'irions from MOPC-?OA myeloma 
.....  ~  ,,.~  .........  ells have an envelope antigen 
GCSA,  xVEA  GCSA  PC  (xVEA)that is absent  from 
PC  passage A Gross MuLV. 
!  @  ,,  is 
with normal  BALB  ~.  ~  ~  J~-  ....  ;~VEA is not PC. 
spleen ceils  GCSA  xVEA  GCSA  ~all  negative) 
(B6xDBA/2)EI  with Eo'G2 Gross  ~'~}  anti-MOPC-70A  ~  ~,~  ....  ~  ......  Confirms that  xVEA isabsent 
myeloma ceils  leukemia ceils  PC  xVEA  (all negative)  PC  from passage A Gross MuLV. 
~.  <o> 
with both of the  ___~  __~..,~  xVEA occurs only on virions, 
above  xVEA  (all negative I  ~(a-li negative~  not on the cell surface. 
with MOPC-70A  _  _ Jr,~-  .... ~-  ........  Control; all activities removed 
myeloma cells  (all negative )  ( all negative )  (all negative )  by absorption with MOPC-70A 
from untreated  ....  ~  ....  ~  Aged NZB mice form anti - GVEA. 
aged NZB mice  --  (?)  GVEA  (GVEA)  (all negativ~ 
Fj  aoti-  ~  (W/FuxBN) 
W/Fu (C58NT)D  in vivo in B6 mice  .....  ~  ~  =,,~  -  GVEA (as well as xVEAI is present 
(Standard rat MuLV  to remove natural  GCSA  GVEA  GCSA GVEA  (all negative)  (and  on virions from MOPC-70A cells 
Gross typing serum)  heteroantibody  G'x?!  1 
FIG.  6.  Summary analysis of  GMuLV antigens and PC  alloantigen on myeloma cells, 
leukemia cells,  and spleen cells. FIo.  7.  BALB  spleen  cells  (middle-size  lymphocytes)  were  reacted  with  the  standard 
PC.1  typing serum  (B6  X  DBA/2)  t"1 anlI-BALB  ~yeloma MOPC-70A  and  labeled  with 
SBMV. Small sectors on the cell surface are labeled with SBMV.  X  18,000. 
FIG.  8.  Higher magnification of one area in Fig.  7,  showing several of the discrete SBMV- 
marked PC.1 seclors.  X  30,000. TADAO  AOKI  AND  TOSHITADA  TAKAHASHI  451 
from wild-type Gross virus. The absorption tests illustrated  in Figs. 6  and  11 
confirm these conclusions. 
The presence of xVEA on the myeloma virions precludes an absolute answer 
as to whether PC may be represented on the myeloma virions; this would re- 
quire  a  demonstration  that  absorption  with  xVEA+PC  -  cells  (of  which  no 
examples are known  so far) would  remove all reaction with myeloma virions 
while leaving PC cell-surface reactivity intact. 
The two other entries in Fig. 6 are included as controls. The serum of aged 
(autoimmune) mice of the NZB strain contains anti-GVEA antibody reactive 
with both the myeloma (Figs. 12 and 13) and the leukemia virions (Fig. 14), and 
so does the standard GMuLV typing serum produced by rats (Figs. 15 and 16). 
The  latter,  as  expected,  also  gave  cell-surface  reactions  referable  to  GCSA 
(and perhaps also to Gzx antigen, see reference 17). The reaction of autoimmune 
NZB mouse serum with the myeloma cell surface has not been identified. 
DISCUSSION 
Alloantigens.--In a previous study, neither H-2  b alloantigen nor the MuLV- 
associated cell-surface antigen,  GCSA, was present on the envelope of virions 
produced by cells bearing these antigens. This conclusion can now be extended 
to the differentiation alloantigens (13,  14),  0, Ly-A, and Ly-B. The occasional 
H-2  k labeling of a small sector of some virions coming from H-2  k leukemia cells is 
a fact to take note of, for it was not seen with H-2  s, and these two H-2 alleles 
confer,  respectively,  sensitivity  and  resistance  to  leukemia  induction  by 
GMuLV  (18-20).  We noted earlier  that the invariable absence of H-2  s  from 
virions produced by Eo  z G2 leukemia cells suggests that they are made prefer- 
entially at H-2- regions of the cell surface; evidently the same may not hold for 
H-2  b and this may have something to do with the mediation of susceptibility of 
H-2  k mice vs. H-2  b mice. 
The occasional  0-labeling of some virions produced by Eo  z G2 leukemia cells 
may similarly indicate that MuLV does not preferentially select either 0- or 0  + 
regions of the cell surface for maturation sites; and in fact the fraction of virions 
showing a  0-labeled sector is roughly equivalent to the fraction of the Ec~G2 
cell surface which bears 0-antigen. In such circumstances it is not very surpris- 
ing to find that such an alloantigen is occasionally and fortuitously associated 
with the surface of the virion. It seems highly unlikely that the respective allo- 
antisera could neutralize any but an insignificant fraction of the infectivity of 
the virus population concerned. 
Turning to the general topic of cell-surface constitution, it is interesting  that 
according  to IEM the phenotype of the  two leukemias, with  respect to their 
surface differentiation alloantigens (13,  14),  was  0+Ly-A+Ly-B  -  (E•G2)  and 
O-Ly-A-Ly-B + (K36)  (Fig.  1). This accords with  serological absorption tests 
{personal observations). Clearly the plasma membrane components recognized FIG.  9.  Ec?G2 cells were reacted  with the standard PC.1  typing serum (B6 X  DBA/2) 
F1 anti-BALB  mydoma MOPC-70A and  labeled  with  SBMV.  One large  sector on  the  cell 
surface is labeled  with  SBMV,  showing GCSA  +,  but  the  envelope of budding virus in  the 
middle of GCSA  + area is not labeled  at all.  X  144,000. 
FIG.  10.  BALB  myeloma MOPC-70A  cells  were reacted  with the standard  PC.1  typing 
serum (B6 X  DBA/'2) F1 anti--'llOPC-70A and labeled with SBMV. Both the discrete areas 
on the cell surface and the en tire envelope of budding viruses are labeled with SB MV. )4 144,000. TADAO AOKI AND  TOSHITADA TAKAIIASHI  453 
as 0-antigen or as antigens of the Ly series are not essential to cell viability, for 
in fact they are limited to certain cell types only. Their loss from malignant cells 
therefore may be inconsequential,  which  may not be the  case with  the//-2 
locus, whose products are found on possibly all cells and may constitute essential 
elements of the plasma membrane. (Loss of the antigens of one/t-2 haplotype 
from malignant cells occurs readily under circumstances of immunoselection, 
but losses of entire H-2 complements have not been found; one explanation of 
this is that  the products of the//-2 locus itself are essential to cell viability 
[see references 13 and 21]). The fact that bothleukemias retain at least oneof the 
markers, 0, Ly-A, and Ly-B, identifies them as derivatives of the T  lymphocyte 
(22).  It seems highly likely therefore that the selective loss of these antigens 
from the  two  leukemias  (assuming  the  losses  to  be  absolute)  has produced 
phenotypes that have no counterpart in the  nonmalignant precursor popula- 
tion. Whether the loss is due to exclusion of the coding genes, as is probably the 
case with the H-2 haplotype losses mentioned above, or whether it is epigenetic, 
is unknown. 
MuLV-Rdated Antigens.--The finding of a new VEA on virions produced by 
myeloma MOPC-70A was an unexpected outcome of testing for PC.1 antigen. 
The PC typing serum is monospecific for PC.1  antigen in cytotoxic tests, but 
IEM shows it contains anti-GCSA  (cell-surface antigen specified by GMuLV) 
and also antibody to the new VEA antigen which denotes the virus produced by 
MOPC-70A as an MuLV subtype vis-a-vis passage A Gross MuLV. 
The identification of the MOPC-70A-myeloma virus as a  distinct  subtype 
may help explain the usual phenotype of these cells, which is GCSA+G~x  -  (23). 
(In normal mice, Gzx is a  thymocyte-ditterentiation alloantigen whose expres- 
sion is dependent on two cellular genes, one of them at the Gxx locus in linkage 
group IX; if MuLV is productively expressed, however, the  rule is that Gxx 
antigen will be expressed, regardless of the inherited  cellular genotype. Thus 
MuLV- to MuLV  + conversion of Gxx-- cells is generally accompanied by Gzx- to 
G,x  + conversion.) The MOPC-70A virus may now perhaps be classed with the 
Friend,  Moloney, and Rauscher variants, all of which induce the GCSA  + but 
not the G,x  + (23) phenotype. The Gxx- to G,x  + conversion may therefore be a 
particular function of wild-type GMuLV as represented in AKR and C58 mice 
and the derivative passage A Gross virus. 
SLrM31&RY 
Immunoelectron microscopy (IEM)  of mouse cells which were productively 
infected with murine leukemia virus (MuLV) yielded the following conclusions: 
FIG. 11.  BALB  myeloma MOPC-70A cells were reacted with the standard PC.1 typing 
serum (B6 X  DBA/2) F1 anti-MOPC-70A previously absorbed with EcPG2 cells, and labeled 
with SBMV. The cell surface is nearly negative, but the entire envelope of budding virus re- 
mains labeled with SBMV, showing GVEA of MOPC-70A virions different from GVEA of 
EoZG2 virions. X 144,000. Fins.  12  and  13.  BALB myeloma MOPC-70A cells were reacted with the serum of aged 
(autoimmune) NZB mice and labeled with SBMV. The entire envelope of budding viruses at 
the initial  stage  (Fig.  12)  and at  the advanced stage  (Fig.  13)  and  minute areas on the cell 
surface are labeled with SBMV.  X  144,000. 
Fro.  14.  EcPG2 cells were reacted with the serum of aged  (autoimmune) NZB mice  and 
labeled  with  SBMV.  The  entire  envelope  of  both  complete  and  budding viruses is labeled 
with SBMV but the cell surface is not labeled at all.  X  144,000. 
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FIG. 15.  BALB myeloma MOPC-70A cells were reacted with the standard GMuLV typing 
rat  serum  (W/Fu X  BN) F1 anti-W/Fu  (C5SNT)D and labeled with ferritin. The  entire 
envelope of  budding virus  and  small sectors  on  the cell surface  are  labeled  with ferritin. 
X  144,000. 
FiG. 16.  Ec~G2 ceils were reacted with the standard GMuLV typing rat serum (W/Fu X 
BN) Fi anti-W/Fu (C58NT)D and labeled with ferritin. The entire envelope of virions and 
small sectors on the cell surface are labeled with ferritin. X  144,000. 
With  two  exceptions,  the  alloantigens  H-2,  0,  Ly-A,  and  Ly-B  were  not 
present  on  complete  or  incomplete  virions  produced  by  cells  bearing  these 
antigens.  The  exceptions were  H-2 k  (but  not H-2 u)  and  0;  both  appeared  on 
only a  minority of virions and  never on more  than  a  small part  of the circum- 
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The  incidental  discovery of an additional  envelope antigen  on virions pro- 
duced by a BALB/c mouse  myeloma but lacking from passage A  Gross virions 
distinguishes these two viruses as MuLV subtypes; it  also illustrates  that IEM 
can be applied  as a primary tool for antigenic analysis,  as well  as for its usual 
purpose of finding out where antigens are situated. 
We are indebted to Dr. H. A. Wood for supply of SBMV; Doctors L. J. Old, E. A. Boyse, 
:and E. de Harven for valuable advice and discussion; and Mr. M. P. Lardis, Miss S. Ohno, 
and P. A. Johnson for excellent technical assistance. 
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